Literature DB >> 11255328

Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms.

V Descamps1, A Valance, C Edlinger, A M Fillet, M Grossin, B Lebrun-Vignes, S Belaich, B Crickx.   

Abstract

BACKGROUND: There is a current debate regarding the association of human herpesvirus 6 (HHV-6) infection and drug reaction with eosinophilia and systemic symptoms (DRESS).
METHODS: Seven consecutive patients hospitalized with DRESS were enrolled in a prospective study to evaluate evidence of active HHV-6 infection. OBSERVATIONS: The imputable drugs were carbamazepine (5 patients), ibuprofen (1 patient), and sulfasalazine (1 patient). All patients were seropositive for anti-HHV-6 IgG antibodies. Anti-HHV-6 IgM antibodies were detected in 4 of the 7 patients with a seroconversion in 2 patients. Neither anti-cytomegalovirus nor anti-Epstein-Barr virus early antigen IgM antibody was detected. Human herpesvirus 6 genome was not detected by polymerase chain reaction in the first serum sample of all patients. It was weakly detected in skin lesions in the last patient tested by polymerase chain reaction but was not found in uninvolved skin.
CONCLUSIONS: The results suggest an association between HHV-6 active infection (primo-infection or reactivation) and severe DRESS. Absence of anti-cytomegalovirus or anti-Epstein-Barr virus early antigen IgM antibodies argues against a nonspecific viral reactivation. Human herpesvirus 6 infection may play a role in the development of DRESS in susceptible patients. Some drugs with reactive metabolites could favor reactivation and propagation of HHV-6.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255328

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  39 in total

1.  Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome.

Authors:  J Ahluwalia; K Abuabara; M J Perman; A C Yan
Journal:  Br J Dermatol       Date:  2015-02-27       Impact factor: 9.302

2.  [DRESS syndrome after carbamazepine].

Authors:  G Wurpts; H Ott; A Schlüter; M Häusler
Journal:  Hautarzt       Date:  2007-11       Impact factor: 0.751

Review 3.  Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

Authors:  Rebecca Pavlos; Simon Mallal; David Ostrov; Yuri Pompeu; Elizabeth Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Jan-Feb

4.  DRESS with delayed onset acute interstitial nephritis and profound refractory eosinophilia secondary to Vancomycin.

Authors:  Paloma O'Meara; Rozita Borici-Mazi; A Ross Morton; Anne K Ellis
Journal:  Allergy Asthma Clin Immunol       Date:  2011-10-03       Impact factor: 3.406

5.  [Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome].

Authors:  P A Müller; K Amann; E-B Bröcker; A Trautmann
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

6.  Elucidation of the cross-reactive immunoglobulin M response to human herpesviruses 6 and 7 on the basis of neutralizing antibodies.

Authors:  Mariko Yoshida; Sadayoshi Torigoe; Masao Yamada
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

Review 7.  The exanthem of dengue fever: Clinical features of two US tourists traveling abroad.

Authors:  Laura B Pincus; Marc E Grossman; Lindy P Fox
Journal:  J Am Acad Dermatol       Date:  2007-10-24       Impact factor: 11.527

8.  Testing for drug hypersensitivity syndromes.

Authors:  Craig M Rive; Jack Bourke; Elizabeth J Phillips
Journal:  Clin Biochem Rev       Date:  2013-02

Review 9.  Human herpes virus 6B: a possible role in epilepsy?

Authors:  William H Theodore; Leon Epstein; William D Gaillard; Shlomo Shinnar; Mark S Wainwright; Steven Jacobson
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

Review 10.  Drug-induced skin, nail and hair disorders.

Authors:  Laurence Valeyrie-Allanore; Bruno Sassolas; Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.